Analysts Viewpoint Larimar Therapeutics Inc (LRMR) receives an Outperform rating from Leerink Partners Larimar Therapeutics Inc’s recently made public that its Director Flynn James E acquired Company’s shares for reported $37.5 million on
Insiders Updates Larimar Therapeutics Inc [LRMR] stock for 37,499,993 USD was bought by Flynn James E Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Larimar Therapeutics
Analysts Viewpoint Understanding the Risks of Investing in Larimar Therapeutics Inc (LRMR) In a filing, Larimar Therapeutics Inc revealed its Director Flynn James E acquired Company’s shares for reported $37.5 million on